Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Trulieve Cannabis (TCNNF)
OTHER OTC:TCNNF
Holding TCNNF?
Track your performance easily
TCNNF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.75 - $14.50
Previous Close$6.03
Volume262.65K
Average Volume (3M)548.00K
Market Cap
$1.14B
Enterprise Value$1.64B
Total Cash (Recent Filing)$317.85M
Total Debt (Recent Filing)$818.91M
Price to Earnings (P/E)―
Beta1.30
Next Earnings
Mar 26, 2025EPS Estimate
-$0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.74
Shares Outstanding187,324,658
10 Day Avg. Volume877,752
30 Day Avg. Volume548,004
Standard Deviation0.22
R-Squared0.14
Alpha0.00566
Financial Highlights & Ratios
Price to Book (P/B)0.90
Price to Sales (P/S)1.01
Price to Cash Flow (P/CF)9.80
P/FCF Ratio4.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.40
Enterprise Value/Gross Profit2.79
Enterprise Value/Ebitda5.30
Forecast
1Y Price Target
$19.72Price Target Upside226.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Trulieve Cannabis News
PremiumCompany Announcements
Trulieve Expands with New Tampa Dispensary
PremiumCompany Announcements
Trulieve Executives Show Confidence with Share Purchases
PremiumCompany Announcements
Trulieve Expands with New Jacksonville Dispensary
PremiumCompany Announcements
Trulieve Expands with New Florida Dispensaries
Bulls Say, Bears Say
Bulls Say
Financial PerformanceStrong execution allowed Trulieve to exceed both top and bottom-line expectations for the quarter and introduce Q3/24 revenue guidance that’s in line with consensus expectations while also boosting operating cash flow guidance for the year to >$250 million.
Growth PotentialSizable cash pile creates optionality: With $356 million of cash on hand, Trulieve has plenty of firepower to invest in growth catalysts across the board, most notably in its home state of Florida ahead of the November ballot initiative for adult-use cannabis.
Market PositionTrulieve is best positioned to benefit with the largest Florida footprint if Amendment 3 passes.
Bears Say
Market VolatilityVolatility in the stock is likely due to the Amendment 3 vote occurring in Florida.
Profitability PressureThis is expected to pressure gross margin, and in combination with infrastructure investment, it will likely reduce EBITDA dollars and rate in 2H.
Sales DeclineDue to typical retail seasonality and concentrated exposure in FL and AZ, the company expects a mid-single-digit sales decline QoQ.
---
Ownership Overview
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
TCNNF FAQ
What was Trulieve Cannabis’s price range in the past 12 months?
Trulieve Cannabis lowest stock price was $4.75 and its highest was $14.50 in the past 12 months.
What is Trulieve Cannabis’s market cap?
Currently, no data Available
When is Trulieve Cannabis’s upcoming earnings report date?
Trulieve Cannabis’s upcoming earnings report date is Mar 26, 2025 which is in 95 days.
How were Trulieve Cannabis’s earnings last quarter?
Trulieve Cannabis released its earnings results on Nov 05, 2024. The company reported -$0.32 earnings per share for the quarter, missing the consensus estimate of -$0.111 by -$0.209.
Is Trulieve Cannabis overvalued?
According to Wall Street analysts Trulieve Cannabis’s price is currently Undervalued.
Does Trulieve Cannabis pay dividends?
Trulieve Cannabis does not currently pay dividends.
What is Trulieve Cannabis’s EPS estimate?
Trulieve Cannabis’s EPS estimate is -$0.22.
How many shares outstanding does Trulieve Cannabis have?
Trulieve Cannabis has 165,964,300 shares outstanding.
What happened to Trulieve Cannabis’s price movement after its last earnings report?
Trulieve Cannabis reported an EPS of -$0.32 in its last earnings report, missing expectations of -$0.111. Following the earnings report the stock price went down -8.268%.
Which hedge fund is a major shareholder of Trulieve Cannabis?
Currently, no hedge funds are holding shares in TCNNF
---
Trulieve Cannabis Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.72 (226.98% Upside)
$19.72 (226.98% Upside)
Blogger Sentiment
Bullish
TCNNF Sentiment 94%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth $466.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.3%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.47%
12-Months-Change
Fundamentals
Return on Equity
-10.06%
Trailing 12-Months
Asset Growth
3.57%
Trailing 12-Months
Company Description
Trulieve Cannabis
Trulieve Cannabis Corp. engages in the provision of medical cannabis products. The firm cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. Its products include smokable flower, inhalation, oral, sublingual, topical, inter-nasal, and concentrates. The company was founded on September 21, 2018 and is headquartered in Quincy, FL.
---
TCNNF Company Deck
---
TCNNF Earnings Call
Q3 2024
0:00 / 0:00
---
TCNNF Stock 12 Month Forecast
Average Price Target
$19.72
▲(226.98% Upside)
Technical Analysis
Best Analysts Covering TCNNF
1 Year
1 Year Success Rate
6/16 ratings generated profit
1 Year Average Return
+24.98%
reiterated a buy rating last month
Copying Derek Dley's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of +24.98% per trade.
---